Therapeuticsmd Inc (TXMD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 50 | -102 | -653 | -2,181 | -2,433 |
| Depreciation Amortization | 287 | 191 | 95 | 509 | 409 |
| Accounts payable and accrued liabilities | 5 | 92 | -82 | 231 | 207 |
| Other Working Capital | 1,103 | 498 | 975 | 1,660 | 1,097 |
| Other Operating Activity | 634 | 401 | 364 | 951 | 1,873 |
| Operating Cash Flow | $2,079 | $1,080 | $699 | $1,170 | $1,153 |
| Cash Flows From Investing Activities | |||||
| Investing Cash Flow | $N/A | $N/A | $N/A | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Financing Cash Flow | $N/A | $N/A | $N/A | $N/A | $N/A |
| Beginning Cash Position | 5,059 | 5,059 | 5,059 | 4,327 | 4,327 |
| End Cash Position | 7,115 | 6,069 | 5,745 | 5,059 | 5,047 |
| Net Cash Flow | $2,056 | $1,010 | $686 | $732 | $720 |
| Free Cash Flow | |||||
| Operating Cash Flow | 2,079 | 1,080 | 699 | 1,170 | 1,153 |
| Free Cash Flow | 2,079 | 1,080 | 699 | 1,170 | 1,153 |